26.09USD-2.34%Mkt Cap: 3.00B $P/E: —1d ago
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. …
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap3.00B $
Enterprise Value2.56B $
Revenue (TTM)449.61M $
Gross Profit269.07M $
Net Income (TTM)-175.54M $
Revenue/Share4.057 USD
Last Price26.09 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.8K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINKYG9887T1168
Valuation
P/E (Trailing)—
P/E (Forward)-12.63
PEG—
EV/EBITDA-10.31
EV/Revenue5.69
P/S6.50
P/B4.36
EPS (TTM)-1.70
EPS (Forward)-2.06
52W Range
24.7751% of range27.38
52W High27.38 USD
52W Low24.77 USD
Profitability
Gross Margin58.47%
Oper. Margin-71.95%
EBITDA Margin-55.20%
Profit Margin-38.15%
ROE-24.53%
ROA-14.97%
Growth
Revenue Growth-3.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-150.79M $
CapEx (TTM)13.42M $
FCF Margin-18.67%
FCF Yield-2.80%
Net Debt-362.95M $
Net Debt/EBITDA1.46
Balance Sheet
Debt/Equity0.31
Current Ratio2.13
Quick Ratio1.61
Book Value/Sh5.963 USD
Cash/Share5.501 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)32.39 USD
Upside (mean)+24.1%
Target Range24.25 USD – 50.00 USD
$24.25+24.1% to mean$50.00
# Analysts12
Ownership
Shares Out.112.27M
Float91.37M
Insiders2.15%
Institutions41.76%
Short Interest
Short Ratio9.0d
Short % Float5.94%
Short % Out.5.82%
Shares Short6.53M
Short (prev mo.)8.15M
Technical
SMA 5020.25 (+28.8%)
SMA 20019.66 (+32.7%)
Beta0.78
S&P 52W Chg18.16%
Avg Vol (30d)1.54M
Avg Vol (10d)1.81M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—